Literature DB >> 25570492

Item response analysis of Alzheimer's Disease Assessment Scale.

Nishant Verma, Mia K Markey.   

Abstract

Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) suffers from low sensitivity in detecting changes in Alzheimer's disease progression in clinical trials of disease-modifying treatments. A comprehensive psychometric analysis of the items in ADAS-cog assessment can help in identifying and improving the insensitive items. Item response theory provides a suitable framework for investigating the ADAS-cog items; however, it requires prior information on the underlying latent construct for reliable analysis. In this study, we perform an exploratory item response analysis to investigate the latent construct underlying the relationships between the ADAS-cog item responses. The results indicate that the underlying latent construct of ADAS-cog is multidimensional in nature with the latent factors measuring cognitive declines in several domains (such as memory, praxis, and language domains).

Entities:  

Mesh:

Year:  2014        PMID: 25570492     DOI: 10.1109/EMBC.2014.6944124

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Modeling a Composite Score in Parkinson's Disease Using Item Response Theory.

Authors:  Gopichand Gottipati; Mats O Karlsson; Elodie L Plan
Journal:  AAPS J       Date:  2017-02-28       Impact factor: 4.009

2.  New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.

Authors:  Nishant Verma; S Natasha Beretvas; Belen Pascual; Joseph C Masdeu; Mia K Markey
Journal:  Alzheimers Res Ther       Date:  2015-11-12       Impact factor: 6.982

3.  Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Daniël M Jonker; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2020-08-27       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.